HEXARELIN 5 MG

Hexarelin 5 mg – Peptide Hubs

Hexarelin (also known as Examorelin) is a synthetic growth hormone-releasing peptide (GHRP) with one of the strongest GH pulse responses in its class. It is frequently used in research examining muscle development, recovery, pituitary responsiveness, and cardiac tissue regeneration. Peptide Hubs offers Hexarelin in a 5 mg lyophilized vial—ideal for sustained protocols in endocrine and anti-aging research.

Mechanism of Action

Hexarelin binds to the ghrelin receptor (GHS-R1a) and acts directly on the hypothalamus and pituitary to stimulate endogenous GH release. Compared to GHRP-2 or GHRP-6, Hexarelin induces a stronger, more sustained GH pulse without significantly raising appetite. In addition to its GH effects, animal models have shown potential cardioprotective properties. For peer-reviewed data, refer to this NIH article on Hexarelin and cardiac function.

Research Applications

• Growth hormone and IGF-1 upregulation studies
• Muscle repair, strength recovery, and anabolic signaling
• Cardioprotective and myocardial tissue regeneration models
• Anti-aging and metabolic improvement protocols

Hexarelin is often co-administered with CJC-1295 DAC to prolong GH activity, or AOD 9604 in metabolic optimization research. Researchers also stack it with B7-33 for potential synergy in cardiac fibrosis reduction models.

Suggested Experimental Use

• Dosage: 100–200 mcg per injection, 1–2x per day
• Administration: Subcutaneous injection in fasted state
• Cycle Duration: 4–8 weeks in GH optimization studies

Stacking Suggestions

Hexarelin is often combined with synergistic peptides in preclinical settings:

• DSIP – to evaluate GH-related recovery during enhanced sleep protocols
• GHK Basic – for connective tissue and wound healing studies
• FOX04-DRI – in aging-related hormone restoration protocols
• Chonluten – to explore immune/hormonal axis balance under GH stimulation

Safety & Legal Status

Hexarelin is for research use only and is not FDA-approved for human or veterinary use. It exhibits no aromatization, no hepatic stress, and minimal risk of appetite stimulation or prolactin elevation. For updates on clinical research, consult ClinicalTrials.gov.

Frequently Asked Questions